Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Gross Profit: 2017-2021

Historic Gross Profit for Neurocrine Biosciences (NBIX) over the last 5 years, with Sep 2021 value amounting to $291.8 million.

  • Neurocrine Biosciences' Gross Profit rose 14.07% to $291.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.1 billion, marking a year-over-year increase of 3.36%. This contributed to the annual value of $780.7 million for FY2019, which is 74.92% up from last year.
  • Neurocrine Biosciences' Gross Profit amounted to $291.8 million in Q3 2021, which was up 2.10% from $285.8 million recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Gross Profit high stood at $300.0 million for Q2 2020, and its period low was $6.3 million during Q2 2017.
  • Its 3-year average for Gross Profit is $238.3 million, with a median of $238.3 million in 2019.
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 1,430.94% in 2018, then dropped by 4.73% in 2021.
  • Over the past 5 years, Neurocrine Biosciences' Gross Profit (Quarterly) stood at $93.8 million in 2017, then spiked by 38.61% to $130.0 million in 2018, then spiked by 85.88% to $241.6 million in 2019, then increased by 16.33% to $255.8 million in 2020, then grew by 14.07% to $291.8 million in 2021.
  • Its last three reported values are $291.8 million in Q3 2021, $285.8 million for Q2 2021, and $233.7 million during Q1 2021.